0EL:F:F-YIDU TECH INC. DL -00002 (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.334

Change

+0.00 (+1.21)%

Market Cap

USD 0.40B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-29 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

-1.13 (-1.44%)

USD 35.26B
2HE:F Healthequity Inc

+0.50 (+0.74%)

USD 5.98B
4YC:F M3 INC.

+0.05 (+0.61%)

USD 5.81B
6HL0:F R1 RCM Inc

-0.10 (-0.79%)

USD 5.45B
9EH:F Evolent Health Inc

-0.20 (-0.73%)

USD 3.37B
1KJ:F 10X GENOMICS DL -00001

+1.00 (+5.08%)

USD 2.34B
6JM:F JMDC INC.

N/A

USD 1.93B
OC9:F Omnicell Inc

-0.20 (-0.52%)

USD 1.78B
1XZ:F Ping An Healthcare and Technol..

-0.01 (-1.28%)

USD 1.23B
4LL:F Teladoc Inc

+0.06 (+0.86%)

USD 1.23B

ETFs Containing 0EL:F

HKDU:SW UBS(Lux)Fund Solutions .. 4.48 % 0.00 %

N/A

N/A
TILV:CA TD Q International Low Vo.. 1.54 % 0.00 %

N/A

CAD 0.08B
IQLT iShares MSCI Intl Quality.. 0.22 % 0.30 %

+0.10 (+0.00%)

USD 8.18B
IPAC iShares Core MSCI Pacific.. 0.21 % 0.10 %

-0.31 (0.00%)

USD 2.07B
EFA iShares MSCI EAFE ETF 0.00 % 0.31 %

+0.19 (+0.00%)

N/A
EPP iShares MSCI Pacific ex J.. 0.00 % 0.48 %

-0.07 (0.00%)

N/A
EWH iShares MSCI Hong Kong ET.. 0.00 % 0.48 %

+0.04 (+0.00%)

N/A
ZHOK 0.00 % 0.14 %

N/A

N/A
ILV-F:CA 0.00 % 0.00 %

N/A

N/A
RWW:CA 0.00 % 0.66 %

N/A

N/A
IDEV iShares Core MSCI Interna.. 0.00 % 0.03 %

+0.18 (+0.00%)

USD 14.47B
FLHK Franklin FTSE Hong Kong E.. 0.00 % 0.09 %

+0.01 (+0.00%)

USD 0.01B
3012:HK Amundi Hang Seng HK 35 0.00 % 0.00 %

+0.14 (+0.00%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -41.40% 24% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.40% 23% F 11% F
Trailing 12 Months  
Capital Gain -26.75% 48% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -26.75% 46% F 22% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -14.78% 33% F 16% F
Dividend Return -14.78% 32% F 15% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.61% 71% C- 61% D-
Risk Adjusted Return -71.70% 23% F 13% F
Market Capitalization 0.40B 68% D+ 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.